Their findings suggest that IL-6 can stimulate pancreatic cancer cells to release Th2 cytokines, consequently fostering the generation of Th2 cells and indirectly facilitating immune evasion by tumor cells (40). The gene discussed is IL6; the disease is familial pancreatic carcinoma.